Home » Authors » Don Long

Articles by Don Long

Grow-your-own valves just one of many stem cell possibilities

Nov. 16, 2006

DES vs. BMS? Debate suggests two sides aren t that far apart

Nov. 15, 2006

AHA head: Healthcare elephant must be moved center stage

Nov. 14, 2006

Study identifies absence of data for ICD explants, interrogation

Nov. 14, 2006

Corautus cancels VEGF-2 work, makes cuts to preserve cash

Nov. 7, 2006

Not enough gold for FDA to back claim of ‘gold standard’

Nov. 1, 2006

Report from Europe: IMI adds EUR15M to pursue retinal implant clinical trials

Oct. 31, 2006

Report identifies large need to improve FDA 'nano-readiness'

Oct. 12, 2006

Stents get dual-magnet method in new drug delivery approach

Oct. 12, 2006

Report identifies large need to improve FDA ‘nano-readiness’

Oct. 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...